Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.12.7.2 (
hydrogenase
)
3,522
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In Alcaligenes eutrophus, the formation of the hydrogenases and of five new peptides is subject to the
hydrogenase
control system. Of these, the B peptide was purified to homogeneity. This protein (Mr, 37,500) was composed of two identical subunits (Mr, 18,800). Antibodies against the
B protein
were used for its quantification by rocket immunoelectrophoresis. About 4% of the total protein consisted of the
B protein
; its molar ratio to the NAD-linked
hydrogenase
was about 4:1. The
B protein
appeared to be associated with the NAD-linked
hydrogenase
, as shown by gel filtration analysis with Sephadex G-200. The
B protein
was not detected in cells that had not expressed the
hydrogenase
proteins or that lacked the genetic information of the hydrogen-oxidizing character; it was also not detected in Tn5 insertional mutants that were unable to form soluble
hydrogenase
antigens. Immunochemical analysis of other species and genera than A. eutrophus revealed that only strains able to form a NAD-linked
hydrogenase
also formed B-protein antigens. The
B protein
is not required for the catalytic activity of soluble
hydrogenase
in vitro; its function is at present unknown.
...
PMID:Purification and properties of a protein linked to the soluble hydrogenase of hydrogen-oxidizing bacteria. 355 56